Stage Iva Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-30
Clinical Trial Update: Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade [Phase 2]
A Phase 2 clinical trial is evaluating a triple combination of docetaxel, ramucirumab, and pembrolizumab for metastatic or recurrent non-sma…